FDA approves Janssen Biotech's STELARA for Crohns disease

The US Food and Drug Administration FDA has approved Janssen Biotech's STELARA ustekinumab to treat moderately to severely active Crohns disease in adults 18 years or older who have failed or were intolerant to treatment with immunomodulators or corticoste...